September 16th, 2013
Intense Lifestyle Changes May Lengthen Telomeres
Larry Husten, PHD
A very small pilot study offers early evidence that a program of comprehensive lifestyle changes increases telomere length. Telomeres, which have been compared to the plastic caps that prevent shoelaces from unravelling, help protect chromosomes. Telomere length is closely correlated to cellular aging: as we age the telomeres in our cells grow shorter. The new study, published online […]
September 16th, 2013
Realistic Expectations for Renal Denervation
Larry Husten, PHD
Early trials of renal denervation have resulted in extremely impressive drops in systolic blood pressure approximating 30 mm Hg. These results have sparked a great deal of excitement in the hypertension community and stirred the interest of a multitude of medical device companies. Some experts have proclaimed renal denervation a potential “cure” for resistant hypertension, […]
September 13th, 2013
Entering New Territory with the Subcutaneous ICD
John Ryan, MD and Martin C. Burke, D.O.
John Ryan poses questions to Martin Burke, the lead investigator of the pivotal trial for the subcutaneous ICD (S-ICD).
September 5th, 2013
Rosiglitazone Revisited
Richard G. Bach, MD and John Ryan, MD
Richard G. Bach discusses his study group’s observational analysis of data from the BARI 2D trial regarding outcomes associated with rosiglitazone.
September 3rd, 2013
Hearts and Minds
Paddy Barrett, MB BCh BAO MRCPI MCTI
What do cardiologists have yet to do to encourage the adoption of the best behavioral interventions?
September 3rd, 2013
A Transatlantic Taste
Amanda Ruth Vest, MBBS
A fellow wonders about worldwide differences in clinical and research approaches in cardiology, as she attends a session on a controversial area that sits uncomfortably alongside the weight-loss message central to American efforts to improve cardiovascular health.
September 3rd, 2013
Speedy Tour de France Racers Slower to Die
Larry Husten, PHD
For more of our ESC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. In recent years, concerns have been raised about possible adverse cardiovascular effects of intense endurance exercise. Additional concerns have been […]
September 2nd, 2013
Losartan Reduces Aortic Enlargement in Marfan Syndrome
Larry Husten, PHD
The COMPARE study provides the first confirmation that the angiotensin receptor blocker losartan reduces aortic enlargement in Marfan syndrome.
September 2nd, 2013
Cardiovascular Outcome Studies in Diabetes Drugs Finally Arrive
Larry Husten, PHD
Large trials of two diabetes drugs show that they appear to be safe, but do not improve CV outcomes.
August 29th, 2013
Statins Reduce Cardiovascular Events in Elders Without Established CVD
Nicholas Downing, MD
Statins are associated with lower risks for myocardial infarction and stroke among elders without established cardiovascular disease, according to a meta-analysis in the Journal of the American College of Cardiology. The analysis included eight randomized, placebo-controlled trials comprising nearly 25,000 patients aged 65 and older without CVD at baseline. During 3.5 years’ follow-up, statin use was […]
NEJM Journal Watch — Recent Cardiology Articles- Cardiovascular Outcomes of Tirzepatide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction